Real World Experience of Azacitidine + Venetoclax in Acute Myeloid Leukemia Rigorously Following Management Guidelines from Clinical Trial
We showed the need to rigorously follow AZA+VEN dosage but also toxicity guidelines and practice recommendations edited in the clinical trial even in the real world.
Authors
- Karine Risso (ORCID: https://orcid.org/0000-0001-9715-197X)
- Michael L. Loschi (ORCID: https://orcid.org/0000-0002-4460-5939)
- Bérengère Dadone‐Montaudié (ORCID: https://orcid.org/0000-0002-0339-4602)
- Corinne Ferrero‐Vacher
- Sami Benachour
- Alexandre Iat (ORCID: https://orcid.org/0009-0009-5370-9025)
- Thomas Cluzeau (ORCID: https://orcid.org/0000-0002-6745-1127)
- Neila De Pooter
- Ghada Abichou
- Bochra Sedaki
- Joy Mouanes-Abelin
Institutions
- Inserm (FR)
- Université Côte d'Azur (FR)
- Centre Hospitalier Universitaire de Nice (FR)
- Centre Méditerranéen de Médecine Moléculaire (FR)
Publication Details
- Journal
- Acta Haematologica
- Published
- 2025-09-29
- DOI
- https://doi.org/10.1159/000548334
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00